Tuesday, July 21, 2026
🇺🇸 FDA

pharma · Asthma · Multiple Sclerosis · TEVA

Teva Pharma

Teva Pharma GmbH

Teva Pharma patent portfolio — 185 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV HQ
126 Employees
Public company Type
TEVA · NYSE Ticker
Company details
Status
Public
HQ
10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
Employees
126
Programs
7
Drugs
407
Patents
185
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Teva Pharma patents

185 pharmaceutical patents indexed for Teva Pharma. 22 expire within 24 months.

Teva Pharma has 185 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 22 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

185 patents

Patent portfolio

Page 2 of 4

  1. US 8663681

    Oral dosage forms comprising progesterone and methods of making and using the same

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8653060

    Formulations of 6-mercaptopurine

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8647646

    Crystals of laquinimod sodium, and process for the manufacture thereof

    Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8614252

    Crystalline solid rasagiline base

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8598203

    Treatment of Crohn's disease with laquinimod

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8580293

    Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

    Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8569379

    Use of rasagiline for the treatment of olfactory dysfunction

    Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8563014

    Modafinil oral lyophilizate

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8545885

    Stable laquinimod preparations

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8501766

    Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8470344

    Aqueous dispersions and solutions of difficult to dissolve materials and methods of their preparation

    Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8426474

    Antimicrobial wash and carrier solutions and uses thereof

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8415332

    Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

    Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8389228

    Process for the measurement of the potency of glatiramer acetate

    Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8383645

    Stable laquinimod preparations

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8334409

    Process for purifying rasagiline base

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8329696

    Solid state forms of sitagliptin salts

    Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8288342

    Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate

    Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8188067

    Formulations of 6-mercaptopurine

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8183373

    Solid state forms of sitagliptin salts

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8178127

    Stable laquinimod preparations

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8163960

    Process for preparing and drying solid rasagiline base

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8158146

    Stable combinations of amlodipine besylate and benazepril hydrochloride

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8124644

    Carvedilol phosphate

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8114900

    Amorphous carvedilol dihydrogen phosphate

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8080584

    Delayed release rasagiline citrate formulation

    Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8067423

    Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8048222

    Highly pure modafinil

    Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8022094

    Carvedilol phosphate

    Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7989473

    Stable laquinimod preparations

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7968749

    Process for preparing and drying solid rasagiline base

    Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7968511

    Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis

    Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7960586

    Purification of armodafinil

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7928147

    Antimicrobial wash and carrier solutions, and uses thereof

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7923215

    Process for the measurement of the potency of glatiramer acetate

    Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7915423

    Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7915412

    Process for the synthesis of 9-hydroxy risperidone (paliperidone)

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7884208

    Crystals of laquinimod sodium, and process for the manufacture thereof

    Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7855233

    Citrate salt of Rasagiline

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7855190

    Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7855176

    Reduced volume formulation of glatiramer acetate and methods of administration

    Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7815942

    Rasagiline formulations of improved content uniformity

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7750051

    Crystalline solid rasagiline base

    Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7687642

    Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them

    Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7683177

    Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole

    Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7683080

    Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol

    Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7678816

    Method of stabilizing lansoprazole

    Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7674923

    Process for preparing forms of atorvastatin calcium substantially free of impurities

    Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Teva Pharma have?

185 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Teva Pharma patents expire?

22 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.